Innoviva Quick Ratio 2006-2020 | INVA

Historical quick ratio values for Innoviva (INVA) over the last 10 years.
Innoviva Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2020-06-30 $0.00B $0.01B 0.00
2020-03-31 $0.00B $0.00B 0.00
2019-12-31 $0.00B $0.01B 0.00
2019-09-30 $0.00B $0.00B 0.00
2019-06-30 $0.00B $0.01B 0.00
2019-03-31 $0.00B $0.00B 0.00
2018-12-31 $0.00B $0.01B 0.00
2018-09-30 $0.00B $0.00B 0.00
2018-06-30 $0.00B $0.01B 0.00
2018-03-31 $0.00B $0.00B 0.00
2017-12-31 $0.00B $0.04B 0.00
2017-09-30 $0.00B $0.03B 0.00
2017-06-30 $0.00B $0.03B 0.00
2017-03-31 $0.00B $0.02B 0.00
2016-12-31 $0.00B $0.02B 0.00
2016-09-30 $0.00B $0.02B 0.00
2016-06-30 $0.00B $0.02B 0.00
2016-03-31 $0.00B $0.01B 0.00
2015-12-31 $0.00B $0.01B 0.00
2015-09-30 $0.00B $0.01B 0.00
2015-06-30 $0.00B $0.01B 0.00
2015-03-31 $0.00B $0.01B 0.00
2014-12-31 $0.00B $0.01B 0.00
2014-09-30 $0.00B $0.04B 0.00
2014-06-30 $0.00B $0.05B 0.00
2014-03-31 $0.38B $0.04B 8.57
2013-12-31 $0.47B $0.08B 5.60
2013-09-30 $0.51B $0.04B 13.28
2013-06-30 $0.45B $0.04B 11.62
2013-03-31 $0.47B $0.03B 15.83
2012-12-31 $0.25B $0.03B 8.46
2012-09-30 $0.28B $0.03B 10.24
2012-06-30 $0.30B $0.03B 11.60
2012-03-31 $0.00B $0.03B 0.00
2011-12-31 $0.00B $0.05B 0.00
2011-09-30 $0.00B $0.04B 0.00
2011-06-30 $0.00B $0.04B 0.00
2011-03-31 $0.00B $0.03B 0.00
2010-12-31 $0.00B $0.04B 0.00
2010-09-30 $0.00B $0.04B 0.00
2010-06-30 $0.00B $0.04B 0.00
2010-03-31 $0.00B $0.04B 0.00
2009-12-31 $0.00B $0.04B 0.00
2009-09-30 $0.00B $0.04B 0.00
2009-06-30 $0.00B $0.04B 0.00
2009-03-31 $0.00B $0.04B 0.00
2008-12-31 $0.00B $0.04B 0.00
2008-09-30 $0.00B $0.04B 0.00
2008-06-30 $0.00B $0.05B 0.00
2008-03-31 $0.00B $0.05B 0.00
2007-12-31 $0.00B $0.06B 0.00
2007-09-30 $0.00B $0.06B 0.00
2007-06-30 $0.00B $0.06B 0.00
2007-03-31 $0.00B $0.06B 0.00
2006-12-31 $0.00B $0.06B 0.00
2006-09-30 $0.00B $0.06B 0.00
2006-06-30 $0.00B $0.05B 0.00
2006-03-31 $0.00B $0.05B 0.00
2005-12-31 $0.00B $0.05B 0.00
2005-09-30 $0.00B $0.04B 0.00
2005-06-30 $0.00B $0.04B 0.00
2005-03-31 $0.00B $0.04B 0.00
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $1.173B $0.261B
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $392.765B 18.72
Roche Holding AG (RHHBY) Switzerland $320.783B 0.00
Merck (MRK) United States $217.034B 15.49
Novartis AG (NVS) Switzerland $208.134B 16.18
Pfizer (PFE) United States $203.549B 12.72
Novo Nordisk (NVO) Denmark $163.517B 26.61
AbbVie (ABBV) United States $159.029B 9.69
AstraZeneca (AZN) United Kingdom $148.146B 28.80
Eli Lilly (LLY) United States $147.459B 22.51
Sanofi (SNY) $131.317B 15.61
GlaxoSmithKline (GSK) United Kingdom $98.485B 12.91
Bayer (BAYRY) Germany $63.190B 9.11
H Lundbeck (HLUYY) Denmark $6.681B 11.61